View in EDS

Transthyretin stabilizer therapy increases naturally-occurring antibodies in ATTR cardiomyopathy.

Saved in:
Bibliographic Details
Title: Transthyretin stabilizer therapy increases naturally-occurring antibodies in ATTR cardiomyopathy.
Authors: Settelmeier, Stephan1,2 (AUTHOR), Agranovski, Daniel3 (AUTHOR), Steinhardt, Maximilian4,5 (AUTHOR), Waydhas, Sarah1,2 (AUTHOR), Gering, Ian6 (AUTHOR), Cejka, Vladimir4 (AUTHOR), Morbach, Caroline4,7,8 (AUTHOR), Störk, Stefan4,7 (AUTHOR), Willbold, Dieter6,9 (AUTHOR), Küppers, Ralf10 (AUTHOR), Vogel, Julia1,2 (AUTHOR), Michel, Lars1,2 (AUTHOR), Carpinteiro, Alexander2,11 (AUTHOR), Reinhardt, H. Christian2,11 (AUTHOR), Dodel, Richard3 (AUTHOR), Rassaf, Tienush1,2 (AUTHOR), Ross, Alexander J.3 (AUTHOR), Hendgen-Cotta, Ulrike B.1,2 (AUTHOR) ulrike.hendgen-cotta@uk-essen.de
Source: Amyloid. Apr2026, p1-17. 17p. 4 Illustrations.
Database: Academic Search Ultimate
Description
ISSN:13506129
DOI:10.1080/13506129.2026.2651299